Valuation : Hypera S.A.

Market Cap 1.6TCr 314Cr 270.54Cr 256.17Cr 232.19Cr 435.6Cr 30TCr 437.81Cr 3.04TCr 1.17TCr 15TCr 1.18TCr 1.15TCr 48TCr P/E 2026 *
8.39x
P/E 2027 * 7.07x
Enterprise Value 2.22TCr 434.14Cr 374.05Cr 354.18Cr 321.03Cr 602.27Cr 41TCr 605.32Cr 4.21TCr 1.62TCr 21TCr 1.63TCr 1.59TCr 67TCr EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.11x
Free-Float
38.88%
Yield 2026 *
5.22%
Yield 2027 * 4.85%
1 day-1.12%
1 week-1.56%
Current month+4.24%
1 month+7.52%
3 months+9.65%
6 months+7.00%
Current year+7.07%
1 week 4.31
Extreme 4.31
4.54
1 month 3.96
Extreme 3.96
4.54
Current year 3.75
Extreme 3.75
5.5
1 year 3.71
Extreme 3.71
5.5
3 years 2.64
Extreme 2.64
8.26
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 50 24/04/2019
Director of Finance/CFO 38 24/02/2022
Chief Operating Officer 40 01/01/2020
Director TitleAgeSince
Director/Board Member 77 01/06/2007
Director/Board Member 60 01/06/2007
Director/Board Member 52 26/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%-1.56% - - 314Cr
-0.65%-2.93%+47.52%+87.34% 99TCr
-0.29%-3.51%+48.78%+63.27% 64TCr
+0.83%+0.26%+16.76%+72.52% 45TCr
-0.38%-3.59%+28.24%+35.57% 34TCr
-0.09%-13.54%+10.08%+26.87% 26TCr
-0.43%-2.48%-2.07%+11.48% 25TCr
-1.34%-13.70%+33.47%+44.18% 20TCr
-3.44%-7.51%-20.08%-59.58% 19TCr
-0.75%-4.82%+21.94%+86.55% 18TCr
Average -0.77%-5.76%+20.52%+40.91% 38.94TCr
Weighted average by Cap. -0.51%-4.42%+29.87%+55.71%

Financials

2026 *2027 *
Net sales 924.05Cr 181.09Cr 156.03Cr 147.73Cr 133.91Cr 251.22Cr 17TCr 252.49Cr 1.75TCr 674.73Cr 8.8TCr 680.09Cr 665.17Cr 28TCr 1.01TCr 197.72Cr 170.35Cr 161.3Cr 146.2Cr 274.29Cr 19TCr 275.68Cr 1.92TCr 736.7Cr 9.61TCr 742.55Cr 726.26Cr 30TCr
Net income 190.54Cr 37Cr 32Cr 30Cr 28Cr 52Cr 3.57TCr 52Cr 361.81Cr 139.13Cr 1.81TCr 140.24Cr 137.16Cr 5.73TCr 222.07Cr 44Cr 37Cr 36Cr 32Cr 60Cr 4.16TCr 61Cr 421.67Cr 162.15Cr 2.12TCr 163.44Cr 159.85Cr 6.68TCr
Net Debt 613.03Cr 120.14Cr 103.51Cr 98Cr 89Cr 166.66Cr 11TCr 167.51Cr 1.16TCr 447.63Cr 5.84TCr 451.18Cr 441.29Cr 18TCr 528.11Cr 103.49Cr 89Cr 84Cr 77Cr 143.57Cr 9.89TCr 144.3Cr 1TCr 385.62Cr 5.03TCr 388.68Cr 380.15Cr 16TCr
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
11/26/11 $4.430 -1.12% 35,818
10/26/10 $4.480 +0.90% 1,661
09/26/09 $4.440 -0.62% 126
08/26/08 $4.468 -0.72% 1,762
04/26/04 $4.500 +1.58% 2,113
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
22.76BRL
Average target price
29.53BRL
Spread / Average Target
+29.76%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!